脉平片佐治ST段抬高性心肌梗死临床观察被引量：1

下载PDF

导出

摘要随着人们生活水平的提高，冠心病、急性心肌梗死的发生率明显增高。虽然急诊行经皮冠状动脉介入术已成为ST段抬高性心肌梗死的首选治疗方法，但对于无条件施行介入治疗的基层医院，溶栓治疗仍为首选。有资料显示，炎症反应在急性冠脉综合征及急性心肌梗死再灌注损伤中起着重要作用。目前，如何减轻再灌注的炎症反应，保护心肌、改善心功能是临床治疗的一大热点。

作者朱喜萍

机构地区高平市人民医院

出处《中国中医药信息杂志》 CAS CSCD 2008年第12期73-73,76,共2页 Chinese Journal of Information on Traditional Chinese Medicine

关键词 ST段抬高性心肌梗死再灌注损伤脉平片

分类号 R259.422.2 [医药卫生—中西医结合]

引文网络
相关文献

参考文献4

1张梅,黄体钢,周丽娟,张一芝,张伟函.急症PCI对急性心肌梗死患者IL-6、CRP和SAA的影响[J].岭南心血管病杂志,2004,10(6):412-415. 被引量：10
2高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量：4974
3汪明灯,高修仁.炎症细胞因子与慢性心力衰竭[J].新医学,2006,37(3):200-202. 被引量：34
4潘德茂,卢健坤,郑朝日.血清白介素-6 C反应蛋白水平和急性冠状动脉综合征的关系──附30例检测报告[J].新医学,2003,34(8):493-494. 被引量：7

二级参考文献49

1Maseri A. Inflammation, atherosclerosis, and ischemic events--exploring the hidden side of the moon. N Engl J Med, 1997, 336(14):1014-1016.
2Maseri A, Liuzzo G, Biasucci LM. Pathogenic mechanisms in unstable angina. Heart, 1999, 82(Suppl 1): 12-14.
3Sturk A, Hack CE, Aarden LA, et al. Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med, 1992, 119(5): 574-579.
4Musial J, Pajak A, Undas A, et al. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample. Thromb Haemost, 1997, 77(4): 697-700.
5HIGUCHI Y,MCTIERNAN C F,FRYE C B,et al.Tumor necrosis factor receptors 1 and 2 differentially regulate survival,cardiac dysfunction,and remodeling in transgenic mice with tumor necrosis factor-alpha induced cardiomyopathy [J].Circulation,2004,109 (15):1892-1897.
6TSUTAMOTO T,WADA A,OHNISHI M T,et al.Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy [ J ].Eur J Heart Fail,2004,6(2):173-180.
7GAO C Q,SAWICKI G,SUAREZ-PINZON W L,et al.Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction[J].Cardiovasc Res,2003,57 (2):426-433.
8SETSUTA K,SEINO Y,OGAWA T,et al.Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/ Fas ligand system [J].Jpn Circ J,2004,68 (8):747-750.
9DESWAL A,BOZKURT B,SETA Y,et al.Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel,etanercept) in patients with advanced heart failure [ J].Circulation,1999,99 (25):3224-3226.
10MANN D L,MCMURRAY J J,PACKER M,et al.Targeted anticytokine therapy in patients with chronic heart failure:results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) [ J ].Circulation,2004,109 (13):1594-1602.